Category: Disclosures

[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-08

November 8, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS is hosting multiple investor relations events via conference calls and in-person meetings to explain the background of its rights offering, review Q3 2024 earnings, and attend investor conferences. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 IR Hosting…

Disclosures, Semiconductors

[Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement (ALT-B4 Technology) / 2024-11-08

November 8, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Alteogen executed an exclusive license agreement with Daiichi Sankyo for the development and commercialization of a subcutaneous (SC) formulation of the ADC therapy Enhertu® using ALT-B4 technology, featuring an upfront payment of approx. KRW 28.0B and milestones up to approx. KRW 391.7B. 📊 [Key Disclosure Details…

Disclosures, Bio & Healthcare

[Disclosure] ALTEOGEN (196170) – Holding of Investor Relations (IR) Session / 2024-11-08

November 8, 2024August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Alteogen will hold an in-person Investor Relations (IR) conference for domestic and foreign securities analysts in Yeouido on November 12, 2024, to enhance corporate understanding and deliver accurate information. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying IR Presentation…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Provisional Sales Results (Consolidated Financial Statements) / 2024-11-08

November 8, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion reported its provisional Q3 2024 consolidated financial results, recording revenue of approximately KRW 881.9B and operating profit of approximately KRW 207.7B, representing a 186.51% QoQ increase in operating profit. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Provisional Sales Results / 2024-11-08

November 8, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion reported its provisional Q3 2024 separate financial results, recording revenue of approximately KRW 1.04T and operating profit of approximately KRW 461.7B, representing a 47.47% QoQ increase in operating profit. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Comparison Between…

Bio & Healthcare, Disclosures

[Disclosure] Celltrion (068270) – Additional Listing (Stock Option Exercise) / 2024-11-08

November 8, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced the additional listing of 57,364 new common shares on November 13, 2024, issued following the exercise of stock options. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Total Issued Shares and Stock Quantity Changes Post-Listing This…

Disclosures, Bio & Healthcare

[Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Equity-Related Bonds / 2024-11-08

November 8, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has decided to acquire KRW 42.0B worth of the 2nd unregistered private convertible bonds issued by JEIO in cash to diversify its business and secure new growth drivers. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of…

Semiconductors, Disclosures

[Disclosure] KEPCO (015760 / KEP) – Pre-announcement of Financial Results / 2024-11-08

November 8, 2024August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO has announced in advance that it plans to disclose its Q3 2024 (Jan–Sep) consolidated financial results on November 13, 2024. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Timely Earnings Release and Subsequent…

Disclosures, Energy

[Disclosure] KEPCO (015760 / KEP) – Investor Relations (IR) Announcement / 2024-11-08

November 8, 2024August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO will hold an Investor Relations (IR) conference call on November 13, 2024, to announce its Q3 2024 earnings results, with IR materials to be published on November 18. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Disclosures, Energy

[Disclosure] LEENO Industrial (058470) – New Facility Investment / 2024-11-08

November 8, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary LEENO Industrial has resolved to invest KRW 97.18 billion (17.45% of total equity) to construct a new factory aimed at expanding production capacity and R&D capabilities. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Construction Progress and Final…

Semiconductors, Disclosures